By Drug Class / Mechanism

Whole-Genome Sequencing (WGS) Market Analysis

Cross-industry research covering Whole-Genome Sequencing (WGS) across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering Whole-Genome Sequencing (WGS)

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

WGS crossed the USD 299 consumer threshold in 2024, and our base case projects the price reaching USD 199 by 2027 (Claritas model), driven by Illumina's NovaSeq X platform economics and emerging competition from Oxford Nanopore's long-read technology. WGS is the fastest-growing assay type and will likely surpass targeted panels in absolute revenue by 2031.

16%

Market Share

13.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments